ifosfamide has been researched along with Diabetes Insipidus in 3 studies
Diabetes Insipidus: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diabetes insipidus is also a rare complication of ifosfamide-induced renal disease." | 6.50 | Ifosfamide-induced Fanconi syndrome with diabetes insipidus. ( Kang, BD; Kim, HS; Kim, MH; Leem, AY; Rha, SY; Yoo, BW, 2014) |
| " All 21 patients with DI required daily change in dosage and schedule of DDAVP." | 5.36 | Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy. ( Afzal, S; Bartels, U; Bouffet, E; Huang, A; Stephens, D; Tabori, U; Wherrett, D, 2010) |
| "Diabetes insipidus is also a rare complication of ifosfamide-induced renal disease." | 2.50 | Ifosfamide-induced Fanconi syndrome with diabetes insipidus. ( Kang, BD; Kim, HS; Kim, MH; Leem, AY; Rha, SY; Yoo, BW, 2014) |
| " All 21 patients with DI required daily change in dosage and schedule of DDAVP." | 1.36 | Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy. ( Afzal, S; Bartels, U; Bouffet, E; Huang, A; Stephens, D; Tabori, U; Wherrett, D, 2010) |
| "Suprasellar germinomas are rare intracranial neoplasms, which mainly occur in children and adolescents and manifest with endocrine symptoms and/or compression syndromes." | 1.34 | [Long-term follow-up of patients with suprasellar germinomas]. ( Bauditz, J; Lochs, H; Ventz, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leem, AY | 1 |
| Kim, HS | 2 |
| Yoo, BW | 1 |
| Kang, BD | 1 |
| Kim, MH | 1 |
| Rha, SY | 1 |
| Afzal, S | 1 |
| Wherrett, D | 1 |
| Bartels, U | 1 |
| Tabori, U | 1 |
| Huang, A | 1 |
| Stephens, D | 1 |
| Bouffet, E | 1 |
| Bauditz, J | 1 |
| Lochs, H | 1 |
| Ventz, M | 1 |
1 review available for ifosfamide and Diabetes Insipidus
| Article | Year |
|---|---|
Ifosfamide-induced Fanconi syndrome with diabetes insipidus.
Topics: Acidosis; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Diabetes Insipidus; Fanconi Syn | 2014 |
2 other studies available for ifosfamide and Diabetes Insipidus
| Article | Year |
|---|---|
Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; | 2010 |
[Long-term follow-up of patients with suprasellar germinomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin | 2007 |